
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
Steminent Biotherapeutics Inc. is the leading stem cell clinical development company in Taipei, with subsidiaries in San Diego and Shanghai, dedicated to the development of novel cellular therapeutics for the treatment of diseases with unmet or under-served medical needs. Steminent utilizes advanced, proprietary processes and know how to isolate, purify, amplify and manufacture standardized stem cell products of the highest quality for research and clinical development in multiple indications. Steminents Stemchymal allogeneic cell therapy R&D program has generated a portfolio of clinical stage therapeutic candidates for multiple diseases including: Phase II; Spinocerebellar Ataxia (PolyQ SCA), Phase I; Osteoarthritis of the...
Degenerative diseases,cell therapy,neurodegenerative disease,musculoskeletal diseases,liver diseases,spinocerebellar ataxia,osteoarthritis knee,acute liver failure,and drug induced liver injury
Steminent biotherapeutics operates in the Biotechnology research industry.
Steminent biotherapeutics's revenue is 11m - 100m
Steminent biotherapeutics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.